SEC Form 4 insider trading filings tracked in real time from EDGAR

Gengos Andrew — Chief Financial Officer

Insider trading activity for Gengos Andrew sourced from SEC EDGAR Form 4 filings.

Overview

  • Title: Chief Financial Officer
  • Company: Terns Pharmaceuticals, Inc.
  • Total insider trades: 4
  • Total buy volume: $0
  • Total sell volume: $3.6M
  • Last trade: May 5, 2026

Recent Trades

DateInsiderTicker / Company TypeSharesValue
May 5, 2026 Gengos Andrew TERN Terns Pharmaceuticals, Inc. SELL 137,500 N/A
May 5, 2026 Gengos Andrew TERN Terns Pharmaceuticals, Inc. SELL 750,000 N/A
May 5, 2026 Gengos Andrew TERN Terns Pharmaceuticals, Inc. SELL 68,750 $3.6M
May 5, 2026 Gengos Andrew TERN Terns Pharmaceuticals, Inc. OTHER 40,503 $2.1M

← All executives · Full trades feed